Incon, Immune Checkpoint Inhibitor Theme Rises 5.17%

On the 19th, the immuno-oncology theme showed strength by rising 3.07% compared to the previous day, while Incon, a related stock drawing attention, surged 5.17% compared to the previous day. Incon is known as a specialized manufacturer of video security equipment.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to provisional data compiled at 12:50, foreign investors have sold 18,000 shares of Incon, resulting in a large net sell-off by foreigners.

[Table] Net Trading Volume by Foreign and Institutional Investors (Unit: 10,000 shares)

According to the analysis by Thinkpool RoboAlgorithm RASSI, Incon’s quant financial score is 16.54 points, ranking 10th within the immuno-oncology theme, with higher growth and profitability scores compared to the average of other related stocks. This indicates that Incon’s revenue and net income growth rates are relatively fast compared to other stocks in the theme, and its efficient profit-generating ability is also favorable.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of RoboAlgorithm’s analysis based on each company’s revenue growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.